Thus, we report a new subtype of CMT with metabolic myopathy due to MTPD deficiency caused by mutations of HADHB gene, suggesting that all CMT patients without definite pathogenic mutations should be screened for mutation in HADHA and HADHB genes. This evidence concerns the gene HADHB and metabolic myopathy.